News Irish study promises to revolutionise childhood cancer care A five-year genomics study that aims to transform the care of children with cancer and improve treatment success has launched in Ireland.
R&D Harnessing genetics to propel cancer research and clinical s... When navigating the landscape of pharmaceutical development, clinical trials represent both a crucial checkpoint and a formidable barrier.
R&D Ageing Europe - It’s time we prioritised neurological condit... Europeans are living longer than ever before – tangible proof of the phenomenal advancements in science and healthcare.1,2 However, it comes with a paradoxical rise in nervous sy
R&D Applying genetics to chemistry to find new small molecules For all the advances that have been made in it, drug discovery is still a hit or miss process, as much an art as a science.
R&D Data-driven disease research harnessing the genome Ben Hargreaves speaks to the UK Biobank to learn more about their work building a dataset of 500,000 individuals.
News 23andMe doses first patient in ph2a anti-tumour monotherapy Additionally, the company will be making investor presentations today and next week.
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face